Scholarlink

Background <p>Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by persistent mucosal inflammation and marked clinical heterogeneity, yet the contribution of metabolic dysregulation to disease pathogenesis remains poorly defined. This study aimed to elucidate the role of glycolytic reprogramming in CRSwNP, with a particular focus on eosinophilic CRSwNP (eCRSwNP).</p> Methods <p>Integrated analyses of publicly available bulk RNA-seq data from GSE136825 (28 controls and 42 CRSwNP samples) and single-cell RNA sequencing data from HRA000772 (5 controls, 5 neCRSwNP, and 6 eCRSwNP samples) were performed to characterize metabolic alterations across distinct cell populations in CRSwNP. Glycolytic activity was quantified using pathway enrichment and module scoring approaches. Seurat was used for single-cell analysis, Monocle3 for macrophage trajectory analysis, and CellChat for cell–cell communication analysis. Key findings were further validated in independently collected human nasal tissue samples using RT-qPCR, immunohistochemistry (IHC), and immunofluorescence (IF). A murine model of eCRSwNP was established, and glycolysis was pharmacologically inhibited using 2-deoxy-D-glucose (2-DG) to assess its effects on inflammation and tissue remodeling.</p> Results <p>Glycolytic activity was markedly elevated in nasal polyp tissues, especially in eCRSwNP, with myeloid cells exhibiting the most pronounced metabolic reprogramming. A distinct subset of glycolysis-high, M2-like macrophages characterized by high expression of SPP1 (SPP1⁺ macrophages) was selectively enriched in eCRSwNP and positively correlated with disease severity. These macrophages were actively involved in Th2 inflammatory responses and extracellular matrix remodeling. SPP1⁺ macrophages communicated with Th2 cells, ILC2s, and fibroblasts predominantly through SPP1-CD44 signaling. Importantly, glycolysis inhibition with 2-DG significantly attenuated sinonasal inflammation, polyp-like lesion formation, and collagen deposition in vivo, accompanied by a reduced accumulation of pathogenic SPP1⁺ macrophage subsets.</p> Conclusions <p>This study identifies glycolysis-high SPP1⁺ macrophages as a key pathogenic subset in eCRSwNP and implicates SPP1-CD44-mediated crosstalk as a potential mechanism underlying disease progression. Targeting macrophage glycolysis may represent a potential therapeutic strategy for this disease.</p> Graphic Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Glycolysis-high SPP1⁺ macrophages promote inflammation and tissue remodeling through the SPP1-CD44 axis in eosinophilic chronic rhinosinusitis with nasal polyps

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月22日

查看全文
  • Huiqin Zhou,
  • Ziheng Huang,
  • Yuanyuan Yang,
  • Rongkai Hua,
  • Xuanyu Zhao,
  • Fangzhou Ye,
  • Zhan Zhao,
  • Li Wang,
  • Hongmeng Yu

摘要

Background

Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by persistent mucosal inflammation and marked clinical heterogeneity, yet the contribution of metabolic dysregulation to disease pathogenesis remains poorly defined. This study aimed to elucidate the role of glycolytic reprogramming in CRSwNP, with a particular focus on eosinophilic CRSwNP (eCRSwNP).

Methods

Integrated analyses of publicly available bulk RNA-seq data from GSE136825 (28 controls and 42 CRSwNP samples) and single-cell RNA sequencing data from HRA000772 (5 controls, 5 neCRSwNP, and 6 eCRSwNP samples) were performed to characterize metabolic alterations across distinct cell populations in CRSwNP. Glycolytic activity was quantified using pathway enrichment and module scoring approaches. Seurat was used for single-cell analysis, Monocle3 for macrophage trajectory analysis, and CellChat for cell–cell communication analysis. Key findings were further validated in independently collected human nasal tissue samples using RT-qPCR, immunohistochemistry (IHC), and immunofluorescence (IF). A murine model of eCRSwNP was established, and glycolysis was pharmacologically inhibited using 2-deoxy-D-glucose (2-DG) to assess its effects on inflammation and tissue remodeling.

Results

Glycolytic activity was markedly elevated in nasal polyp tissues, especially in eCRSwNP, with myeloid cells exhibiting the most pronounced metabolic reprogramming. A distinct subset of glycolysis-high, M2-like macrophages characterized by high expression of SPP1 (SPP1⁺ macrophages) was selectively enriched in eCRSwNP and positively correlated with disease severity. These macrophages were actively involved in Th2 inflammatory responses and extracellular matrix remodeling. SPP1⁺ macrophages communicated with Th2 cells, ILC2s, and fibroblasts predominantly through SPP1-CD44 signaling. Importantly, glycolysis inhibition with 2-DG significantly attenuated sinonasal inflammation, polyp-like lesion formation, and collagen deposition in vivo, accompanied by a reduced accumulation of pathogenic SPP1⁺ macrophage subsets.

Conclusions

This study identifies glycolysis-high SPP1⁺ macrophages as a key pathogenic subset in eCRSwNP and implicates SPP1-CD44-mediated crosstalk as a potential mechanism underlying disease progression. Targeting macrophage glycolysis may represent a potential therapeutic strategy for this disease.

Graphic Abstract